Latest Breaking News On - Present new clinical data - Page 1 : comparemela.com

Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting

Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAditi shastriJustine koenigsbergJared gollobEuropean hematology associationExchange commissionMontefiore medical centerAlbert einstein college of medicineKymera therapeutics incPresent new clinical dataOngoing phaseAnnual meetingChief medical officerClinical activityTargeted protein degraderRefractory hematologic

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoMatthew deyoungMeredith pelsterDouglase onsiZev wainbergDrug administrationLeap therapeutics incAmerican society of clinical oncologyGi oncology programPrnewswire leap therapeutics incGastrointestinal research at sarah cannon institutePresent new clinical dataDefiance studyClinical oncology

Wugen to Present New Clinical Data for WU-CART-007 and Preclinical Data for WU-NK-101, Two Investigational Allogeneic Cell Therapies for Challenging Hematologic Cancers, at American Society of Hematology Annual Meeting & Exposition

Wugen to Present New Clinical Data for WU-CART-007 and Preclinical Data for WU-NK-101, Two Investigational Allogeneic Cell Therapies for Challenging Hematologic Cancers, at American Society of Hematology Annual Meeting & Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomSan diegoMark lewisChristine fanelleNupur bhatnagarMetafora biosystemsArmin ghobadiSergio rutellaMarriott marquisNottingham universityDrug administrationAmerican society of hematologyAmerican society of hematology annual meeting expositionWashington university

Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress

Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBruxelles capitaleCity ofOzlem goker alpanNaomi aokiExchange commissionCompany annual report on formTreatment centerEuropean society of gene cell therapyFreeline therapeutics holdingsRare disorders researchHead of investor relations communicationsPresent new clinical dataGaucher diseaseOral presentation

Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast

Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAlexanderi spiraAlisonm schramKathrync arbourW clay gustafsonBiancaj leeExchange commissionInternational conference on molecularRevolution medicines incEuropean society for medical oncology congressExchange commission onCompany to host investor webcast followingPresent new clinical dataMajor oncology conferencesHost investorHost investor webcast following